'Clinical safety' presentation slideshows

CLINICAL SAFETY IN NEUROLOGY

CLINICAL SAFETY IN NEUROLOGY. James Brasic, MD, MPH and Jerry Ainsworth, MD, PhD. ACKNOWLEGMENTS.

532 views • 37 slides

REGULATORY ISSUES FOR THE REGISTRATION PROCESS OF HERBAL PHARMACEUTICAL PRODUCTS IN EUROPE

Dr. F. Qadan, PhD-Germany University of Petra-Amman. REGULATORY ISSUES FOR THE REGISTRATION PROCESS OF HERBAL PHARMACEUTICAL PRODUCTS IN EUROPE. Legal Provisions Relating to Efficacy and Safety of Herbal Medicinal Products

328 views • 32 slides

Safer IT Systems for the NHS

Safer IT Systems for the NHS. Dr. Maureen Baker CBE DM FRCGP Special Clinical Adviser NPSA Clinical Safety Officer CfH. Overview. Patient safety in Connecting for Health NPSA commissioned study Safety Management Requirements IT solutions to patient safety problems Process re-design.

342 views • 21 slides

Safer IT Systems for the NHS

Safer IT Systems for the NHS. Dr. Maureen Baker CBE DM FRCGP Special Clinical Adviser NPSA Clinical Safety Officer CfH. Overview. Patient safety in Connecting for Health NPSA commissioned study Safety Management Requirements IT solutions to patient safety problems Process re-design.

214 views • 21 slides

Regulatory Concepts for Dual Indication Combination Products

Regulatory Concepts for Dual Indication Combination Products. Charu Mullick, M.D. Division of Antiviral Products, CDER U.S. Food and Drug Administration Multipurpose Prevention Technologies Satellite AIDS 2012, Washington D.C. FDA Disclaimer.

304 views • 18 slides

298 views • 16 slides

Patient Safety Science & Technology Summit 2014

Patient Safety Science & Technology Summit 2014. Joshua S. Adler, MD. Chief Medical Officer, UCSF Medical Center and UCSF Benioff Children's Hospital. Why Focus on Culture?.

226 views • 12 slides

Biological Safety Assessment

Writing A Biological Safety Assessment (BSA) Report 1.Clinical Data Evaluation and Evidence 2.Clinical Investigation, Plan and Performance 3.Device Registry 4.Clinical Safety and Use 5.Feasibility Study and Standards 6.Hazard due to substances and technology 7.Post Market Clinical Follow up(PMCF) data and plan visit to know more: https://goo.gl/YJwxco Contact Info: UK: 44-1143520021 US/Canada: 1-972-502-9262 India: 91-8754446690 info@medicalwritingexperts.com www.medicalwritingexperts.com

121 views • 2 slides